BrightSpring Health Services, Inc. BTSG
56.59
0.57
1.02%
as of 25 Sep
- Market cap
- $11.1B
- P/E
- 31.6×
Follow BTSG
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
7.55% | 10.82% | 16.90% | 19.31% | |
| 2.19% | 3.09% | 5.14% | 6.14% | ||
ROIC |
3.61% | 4.28% | 6.35% | 7.56% | |
Return on Tangible Assets |
9.22% | 15.26% | 23.08% | 32.44% | |
Average Days of Receivables |
30.54 | 27.98 | 29.78 | 28.94 | |
Free Cash Flow per Share |
1.36 | 1.95 | 2.01 | 1.95 | |
Free Cash Flow |
276.09 | 394.69 | 412.12 | 402.35 | |
Capital Expenditures |
(73.13) | (95.48) | (99.40) | (104.00) | |
Piotroski F-Score |
6.00 | 7.00 | 7.00 | 7.00 | |
| Other line items | |||||
Cash ROIC |
7.78% | 10.93% | 9.51% | 10.54% | |
Accounts Receivable Turnover |
11.88 | 13.64 | 13.07 | 13.61 | |
Accounts Payable Turnover |
12.27 | 10.64 | 12.23 | 12.25 | |
Inventory Turnover |
19.08 | 15.70 | 21.91 | 20.98 | |
Average Days of Payables |
32.67 | 39.02 | 33.24 | 31.62 | |
Days of Inventory on Hand |
21.88 | 26.12 | 17.06 | 16.67 | |
Tax Rate |
(0.23) | (0.24) | (0.20) | (0.16) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
9.92% | 9.47% | 9.49% | 9.27% | |
Share Based Compensation of Revenue |
0.58% | 0.54% | 0.43% | 0.38% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
2.69 | 2.57 | 1.65 | 1.38 | |
Depreciation/Fixed assets |
1.09 | 0.86 | 0.85 | 0.81 | |
Capex/Depreciation |
(0.38) | (0.54) | (0.58) | (0.60) | |
Revenue per Share |
59.50 | 63.74 | 66.66 | 69.75 | |
Operating CF per Share |
1.72 | 2.42 | 2.50 | 2.46 | |
Capex per Share |
(0.36) | (0.47) | (0.49) | (0.50) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
1.07% | 1.48% | 2.27% | 2.55% |
Columns are period end dates